Compare SNY & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNY | MDT |
|---|---|---|
| Founded | 1994 | 1949 |
| Country | France | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4B | 114.9B |
| IPO Year | N/A | N/A |
| Metric | SNY | MDT |
|---|---|---|
| Price | $49.34 | $101.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 18 |
| Target Price | $61.50 | ★ $108.63 |
| AVG Volume (30 Days) | 2.3M | ★ 7.9M |
| Earning Date | 10-24-2025 | 11-18-2025 |
| Dividend Yield | ★ 3.23% | 2.80% |
| EPS Growth | ★ 105.93 | 12.98 |
| EPS | ★ 8.67 | 3.69 |
| Revenue | ★ $53,890,648,839.00 | $34,758,000,000.00 |
| Revenue This Year | $2.37 | $8.60 |
| Revenue Next Year | $6.51 | $5.83 |
| P/E Ratio | ★ $11.25 | $27.47 |
| Revenue Growth | N/A | ★ 5.34 |
| 52 Week Low | $44.62 | $79.29 |
| 52 Week High | $60.12 | $106.33 |
| Indicator | SNY | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 46.53 | 59.12 |
| Support Level | $48.89 | $101.58 |
| Resistance Level | $50.43 | $105.73 |
| Average True Range (ATR) | 0.73 | 1.90 |
| MACD | -0.15 | -0.03 |
| Stochastic Oscillator | 19.29 | 52.85 |
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.